What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced by COVID-19?

por Gornet, J.-M., Tran Minh, M.L., Leleu, F., Hassid, D.
Publicado 2020

Que doivent savoir les chirurgiens à propos des troubles digestifs et des anomalies paracliniques induits par le COVID 19 ?()

por Gornet, J.-M., Tran Minh, M.L., Leleu, F., Hassid, D.
Publicado 2020

Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens

por du Rusquec, P., Guimbaud, R., Le Malicot, K., Gornet, J.-M., Nguyen, S., Lecomte, T., Khemissa-Akouz, F., Perrier, H., Bouché, O., Paoletti, X., Le Tourneau, C.
Publicado 2023

Early detection of recurrence by (18)FDG-PET in the follow-up of patients with colorectal cancer

por Sobhani, I, Tiret, E, Lebtahi, R, Aparicio, T, Itti, E, Montravers, F, Vaylet, C, Rougier, P, André, T, Gornet, J M, Cherqui, D, Delbaldo, C, Panis, Y, Talbot, J N, Meignan, M, Le Guludec, D
Publicado 2008

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

por Aparicio, T, Svrcek, M, Zaanan, A, Beohou, E, Laforest, A, Afchain, P, Mitry, Emmanuel, Taieb, J, Di Fiore, F, Gornet, J-M, Thirot-Bidault, A, Sobhani, I, Malka, D, Lecomte, T, Locher, C, Bonnetain, F, Laurent-Puig, P
Publicado 2013

Colorectal cancer (CRC) monitoring by 6-monthly (18)FDG-PET/CT: an open-label multicentre randomised trial

por Sobhani, I, Itti, E, Luciani, A, Baumgaertner, I, Layese, R, André, T, Ducreux, M, Gornet, J -M, Goujon, G, Aparicio, T, Taieb, J, Bachet, J -B, Hemery, F, Retbi, A, Mons, M, Flicoteaux, R, Rhein, B, Baron, S, Cherrak, I, Rufat, P, Le Corvoisier, P, de’Angelis, N, Natella, P -A, Maoulida, H, Tournigand, C, Durand Zaleski, I, Bastuji-Garin, S
Publicado 2018